Attached files

file filename
EX-10.3 - EXHIBIT 10.3 - ProUroCare Medical Inc.v327282_ex10-3.htm

 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 29, 2012

  

ProUroCare Medical Inc.

(Exact Name of Registrant as Specified in its Charter)

  

Nevada 000-51774 20-1212923
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
 

 

6440 Flying Cloud Dr., Suite 101, Eden Prairie, Minnesota  55344
(Address of Principal Executive Offices)  (Zip Code)
 
(952) 476-9093
(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)
     

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

Item 1.01 Entry into Material Definitive Agreements

 

The disclosure under Item 2.03 below is incorporated herein by reference.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Company

 

On October 29, 2012, ProUroCare Medical Inc. (the “Company”) borrowed $100,000 pursuant to a secured promissory note issued in favor of Jeanne Rudelius. The note matures on December 26, 2012, and is secured by a subordinated security interest in all Company assets. In lieu of interest or any other consideration, the Company issued 20,000 shares of its common stock to the lender.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits.

 

10.3Promissory Note dated October 29, 2012 issued in favor of Jeanne Rudelius (filed herewith).

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ProUroCare Medical Inc.  
       
       
Date: November 2, 2012 By /s/ Richard C. Carlson  
    Richard C. Carlson  
    Chief Executive Officer